Renaissance Technologies - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 139 filers reported holding CARA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$524
-57.3%
311,900
-28.1%
0.00%
-50.0%
Q2 2023$1,228
+601.7%
434,050
+1120.3%
0.00%
Q1 2023$175
-100.0%
35,568
-77.7%
0.00%
-100.0%
Q1 2022$1,934,000
-56.0%
159,150
-55.9%
0.00%
-60.0%
Q4 2021$4,396,000
+96.9%
360,950
+130.7%
0.01%
+66.7%
Q2 2021$2,233,000
-60.7%
156,460
-40.2%
0.00%
-57.1%
Q1 2021$5,676,000
+34.6%
261,450
-6.2%
0.01%
+40.0%
Q4 2020$4,217,000
+10.9%
278,714
-6.8%
0.01%
+25.0%
Q3 2020$3,804,000
+150.4%
298,964
+236.5%
0.00%
+300.0%
Q2 2020$1,519,000
-71.7%
88,850
-78.5%
0.00%
-83.3%
Q4 2018$5,371,000
+159.5%
413,150
+66.7%
0.01%
+50.0%
Q3 2016$2,070,000
+272.3%
247,900
+177.3%
0.00%
+300.0%
Q1 2016$556,000
-30.7%
89,400
+88.1%
0.00%
-50.0%
Q4 2015$802,000
-77.7%
47,540
-81.1%
0.00%
-77.8%
Q3 2015$3,595,000
+41.6%
251,600
+20.4%
0.01%
+50.0%
Q2 2015$2,538,000
-7.4%
208,887
-23.4%
0.01%0.0%
Q1 2015$2,742,000
+1052.1%
272,800
+1040.6%
0.01%
+500.0%
Q4 2014$238,00023,9180.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders